GLP-1 & weight-loss clinical trials in Colorado
8 GLP-1 or weight-loss trials are recruiting in Colorado as of July 14, 2026, with sites in Aurora, Boulder, Colorado Springs, Lakewood. Many studies reimburse time and travel — the amount is set by each study and confirmed when you contact the team.
- Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome
Phase 3 · ~80 participants · NCT05819853
Studied intervention: Semaglutide Injectable Product (Wegovy and/or Ozempic)
Colorado site: Aurora
- Glucagon-Like Peptide-1 Receptor Agonist in ADPKD
Phase 2 · ~126 participants · NCT06582875
Studied intervention: Tirzepatide
Colorado site: Aurora
- A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Phase 2 · ~465 participants · NCT06717698
Studied intervention: Semaglutide
Colorado site: Aurora
- A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
Phase 3 · ~800 participants · NCT07153471
Studied intervention: Orforglipron
Colorado site: Colorado Springs
- Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents
Phase 1 · ~40 participants · NCT06575738
Studied intervention: Injectable semaglutide
Colorado site: Aurora
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Phase 3 · ~2500 participants · NCT07564414
Studied intervention: Semaglutide
Colorado site: Aurora
- A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Phase 3 · ~1000 participants · NCT07202884
Studied intervention: Orforglipron
Colorado site: Lakewood
- A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
Phase 3 · ~586 participants · NCT07035093
Studied intervention: Retatrutide
Colorado site: Boulder
What joining a GLP-1 trial in Colorado actually involves
Every study above is registered on ClinicalTrials.gov, the US National Library of Medicine's public registry, and each link goes straight to that record — the one place the eligibility criteria, the schedule of visits and the contact details are kept current. A recruiting listing means the study is actively enrolling; it does not mean you are eligible until the study team screens you.
- Reimbursement is not the same as payment. Many studies cover time and travel, but the amount is set per study and confirmed by the team — treat any specific figure you see elsewhere as unverified until they tell you.
- You may receive a placebo. Most of these are randomized, so joining is not a guaranteed route to the active drug. That is worth weighing if your goal is treatment rather than contributing to the evidence.
- Trial participation is free to join and separate from a prescription. If your aim is to start a GLP-1 now, compare the cash-pay routes instead — trials are a different path with a different purpose.
Source: ClinicalTrials.gov (US National Library of Medicine), public-domain data, snapshot July 14, 2026. This is not medical advice or a recruitment service — confirm status, eligibility, and compensation on each linked ClinicalTrials.gov record and discuss any trial with your clinician.